Search Results for: DSP107

Cancer treatment trial extended

The Phase 1 / 2 trial of DSP107 from Israel’s KAHR Medical (see here previously) has commenced and will now be expanded to include blood cancer patients in addition to solid tumors. KAHR has received an additional investment of $5 … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Approval to test treatment for advanced cancer

Israel’s KAHR Medical has received US FDA approval to begin Phase 1 & 2 clinical (human) trials of its DSP107 treatment of advanced solid tumors (reported here previously). The trials will assess DSP107 both by itself and in combination with … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Double-whammy cancer treatment

Israel’s Kahr Medical plans to begin human trials of its DSP107 treatment on lung cancer patients. It will be tested both standalone and in combination with Roche’s Tecentriq (atezolizumab). DSP107 finds and marks cancer cells, then alerts the immune system … Continue reading

Posted in Israel's Medical Achievements | Leave a comment